加味通督活血汤配合椎管减压联合Dynesys系统治疗退行性腰椎管狭窄症的临床疗效研究

Clinical Efficacy of Treatment of Degenerative Lumbar Spinal Stenosis Disease by Modified Tong-Du Activating Blood Decoction and Spinal Decompression Associate with Dynesys System

目的：评价加味通督活血汤配合椎管减压联合Dynesys系统治疗退行性腰椎管狭窄症的临床疗效。方法：2010年1月~2013年12月,对35例退行性腰椎管狭窄的患者进行口服加味通督活血汤配合后路减压联合Dynesys系统置入,并进行临床随访,通过VAS和ODI评分评估临床疗效。结果：28名患者得到满意随访,随访12~35个月（平均22.8个月）,VAS腰痛评分：术前6.5±1.5,术后2.2±1.1;VAS腿痛评分：术前7.8±1.6,术后2.8±1.5。ODI评分：术前（67.5±18.2）%,术后（21.5±12.3）%。参照Nakai标准：优18例;良7例;可3例;差0例,优良率达89.3%。结论：加味通督活血汤配合椎管减压联合Dynesys系统治疗退行性腰椎管狭窄症可获得满意的临床疗效,值得临床广泛推广。

Objective： Clinical efficacy evaluation of spinal decompression associate with Modified Tong-du activating blood decoction and Dynesys system in the treatment of lumbar spinal stenosis. Methods： In January 2010- December 2013, 35 cases of degenerative lumbar spinal stenosis in patients of posterior decompression combined Modified Tong Du activating blood decoction and dynesys system, and clinical follow-up, through VAS and ODI scores to evaluate the clinical curative effect. Results 28 patients get satisfactory follow-up, 12-35 months of follow-up （mean 22. 8 months）, lumbar pain VAS score： preoperatively6. 5 ± 1.5, postoperatively 2. 2 ＋±1.1 ; leg pain VAS score ： preoperativelyT. 8 ±1.6, postoperatively 2. 8 ±1.5. ODI score ： preoperative （ 67.5 ~± 18. 2）%, postoperatively （21.5 ± 12. 3）%. With reference to Nakai standard： Excellent in 18 cases; Good in 7 cases; General in 3 cases; Poor 0 cases, good rate of 89. 3%. Conclusion： Spinal decompression associate with Modified Tong-du activating blood decoction and dynesys system in the treatment of lumbar spinal stenosis can desirable satisfactory early clinical curative effect.